Get Integrated Data for Your Specialty and Interest Aresa
 
Category Select :
Items 161 ~ 180 of 25664, Page 9 of 1284
161. The overlooked benefits of medical scribes - 10/26/2018
 American Medical Association (AMA) News by Andis Robeznieks
  It''s a given that using medical scribes will reduce data-entry time for physicians. But the myriad benefits this produces for patients and physicians are now being quantified by emerging research.
162. New global commitment to primary health care for all at Astana conference - 10/25/2018
 World Health Organization (WHO)
  Declaration of Astana charts course to achieve universal health coverage, 40 years since declaration on primary health care in Alma-Ata
163. Merck Announces Third-Quarter 2018 Financial Results - 10/25/2018
 MERCK
  Third-Quarter 2018 Worldwide Sales Were $10.8 Billion / Third-Quarter 2018 GAAP EPS was $0.73, Third-Quarter Non-GAAP EPS was $1.19 / Company Narrows 2018 Full-Year Revenue Range to be Between $42.1 Billion and $42.7 Billion, Including a Minimal Impact from Foreign Exchange / Results from KEYNOTE-426 Studying KEYTRUDA in Combination with Axitinib as First-line Treatment for Advanced or Metastatic Renal Cell Carcinoma Met Primary Endpoints of Overall Survival and Progression-Free Survival / Company Announces 15 Percent Increase to Quarterly Dividend to 55 Cents Per Outstanding Share and Authorizes an Additional $10 Billion Share Repurchase, Including a $5 Billion Accelerated Share Repurchase Program
164. Abbott Introduces the Next Generation of Influenza A & B and Strep A Assays with Fastest-Ever Time to Molecular Results - 10/25/2018
 Abbott
  ABBOTT PARK, Ill., Oct. 25, 2018 /PRNewswire/ Abbott (NYSE: ABT) announced today that the U.S. Food and Drug Administration (FDA) has cleared its next-generation Influenza A & B 2 and Strep A 2 molecular assays for point-of-care testing1,2. These new assays enable the fastest-ever3 time to molecular influenza A & B and Strep A results at the point of care.4 Currently available on the ID NOW platform (formerly Alere i), both assays have been granted a Clinical Laboratory Improvement Amendments (CLIA) certificate of waiver.
165. Privacy, security guidelines aim to bolster use of mHealth - 10/25/2018
 American Medical Association (AMA) News by Andis Robeznieks
  Privacy and security guidelines aimed at securing the protected health information and personal, identifiable data of mobile health app users have been released for public comment by Xcertia, a nonprofit founded by the AMA and other major health and technology organizations.
166. AMA Announces Updated Tool to Locate Underserved Patient Care Areas - 10/25/2018
 American Medical Association
  Latest version of geospatial mapping tool could be used to assist reporters or researchers hoping to understand trends and gaps in patient access to care.
167. Effect of Lanreotide on Kidney Function in Patients With Autosomal Dominant Polycystic Kidney Disease: The DIPAK 1 Randomized Clinical Trial - 10/25/2018
 JAMA 2018 doi:10.1001/jama.2018.15870
  This randomized clinical trial compares the effect of adding the somatostatin analogue lanreotide to standard care vs standard care alone on change in estimated glomerular filtration rate (eGFR) in patients with autosomal dominant polycystic kidney disease (PCKD).
168. Survey reveals top 6 challenges faced in medical residency - 10/25/2018
 American Medical Association (AMA) News by Brendan Murphy
  For three in five medical residents, nonclinical concerns such as work-life balance, time pressures or debt represent their biggest challenge during in training.
169. Strict EU ruling on gene edited crops squeezes science - 10/25/2018
 Nature News by Andrew J Wight
  Researchers are feeling the pinch and demanding exemptions for plant science and agriculture.
170. Merck Announces Increased Fourth-Quarter Dividend and $10 Billion Share Repurchase Authorization - 10/25/2018
 MERCK
  Increases Quarterly Dividend 15% to $0.55 per Outstanding Share Enters Into a $5 Billion Accelerated Share Repurchase Program Under Expanded Authorization
171. FDA Approves New SynchroMed(TM) II myPTM(TM) Personal Therapy Manager That Enables Patients to Alleviate Unpredictable Pain - 10/24/2018
 Medtronic
  (GLOBE NEWSWIRE via COMTEX) --myPTM Allows Patients to Personalize Their Treatment by Delivering On-Demand Boluses, or Drug Doses, Within Therapeutic Limits Set by Their Physician
172. Overdiagnosis of Penicillin Allergy Leads to Costly, Inappropriate Treatment - 10/24/2018
 JAMA Medical News & Perspectives by Rita Rubin, MA
  This Medical News article discusses why many patients have mistakenly been labeled as allergic to penicillin and the impact that can have on their health.
173. Is There a Seasonal Influence on Cognition and Dementia? - 10/24/2018
 JAMA. Medical News & Perspectives by Jennifer Abbasi
  This Medical News article discusses a recently discovered association between time of year and cognitive performance even in people with Alzheimer disease.
174. Satisfaction in science - 10/24/2018
 Nature: Career Feature by Chris Woolston
  Nature''s survey offers a snapshot of salaries and career paths in the scientific sector.
175. China hides identities of top scientific recruits amidst growing US scrutiny - 10/24/2018
 Nature News by Smriti Mallapaty
  Chinese researchers fear that affiliation with the high-status Thousand Talents scheme could make them targets of FBI investigations.
176. AAOS Statement on Opioid Legislation Becoming Law - 10/24/2018
 American Academy of Orthopaedic Surgeons
  Washington, DC American Association of Orthopaedic Surgeons (AAOS) President David A. Halsey, MD, released the following statement after the Substance Use-Disorder Prevention that Promotes Opioid Recovery and Treatment for Patients and Communities Act (H.R. 6) was signed into law by the president. The bipartisan agreement will help combat the public health crisis, which resulted in more than 72,000 drug-overdose deaths in 2017.
177. American Academy of Orthopaedic Surgeons announces the launch of its Shoulder and Elbow Registry - 10/24/2018
 American Academy of Orthopaedic Surgeons
  Mission to improve orthopaedic care through the collection, analysis, and reporting of actionable data
178. International Innovators in Medical and Surgical Eye Health to Convene in Chicago to Advance Patient Care - 10/24/2018
 American Academy of Ophthalmology
  Thousands of eye physicians and surgeons this week will convene in Chicago to attend AAO 2018, the American Academy of Ophthalmologys 122nd annual meeting.
179. Effect of a Low vs Intermediate Tidal Volume Strategy on Ventilator-Free Days in Intensive Care Unit Patients Without ARDS - 10/24/2018
 JAMA. Published online October 24, 2018. doi:10.1001/jama.2018.14280
  This randomized trial compares the effects of low vs intermediate tidal volumes on ventilator-free days and mortality among intensive care unit (ICU) patients without acute respiratory distress syndrome (ARDS).
180. 6 ways fast-evolving pay models are affecting physician practices - 10/24/2018
 American Medical Association (AMA) News by Andis Robeznieks
  AMA-RAND report: Doctors see opportunity for new payment models to improve care, but are overwhelmed by their complexity and the pace of change.
<<  <  [1]  [2]  [3]  [4]  [5]  [6]  [7]  [8]  [9[10]  >  >>
 


Copyright ~2018 by Medisurf. All Rights Reserved Terms of Service Privacy Email : medalls@medalls.com